Skip to main
APVO
APVO logo

Aptevo Therapeutics (APVO) Market Capitalization Overview

Market Cap: $8.65M as of Aug 1, 2025

$8.65M
Past Month-$1.20M (12.13%)
As of Aug 1, 2025, Aptevo Therapeutics (APVO) has a market capitalization of $8.65M. Over the past 30 days, its market cap has decreased by -9.15%, while in the last 12 months, it has increased by 37.46%.

Market capitalization represents the total value of Aptevo Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Aptevo Therapeutics (APVO) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Aptevo Therapeutics (APVO) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Aptevo Therapeutics (APVO) Market Cap History

DateMarket CapChange
Aug 1, 2025$8.65M-9.15%
Jul 1, 2025$9.52M+184.85%
Jun 2, 2025$3.34M+358.78%
May 1, 2025$727.80K-50.00%
Apr 1, 2025$1.46M-67.70%
Mar 3, 2025$4.51M-28.97%
Feb 3, 2025$6.35M-4.81%
Jan 2, 2025$6.67M+64.66%

Aptevo Therapeutics (APVO) End of Year Market Cap History

DateMarket CapChange
2025$8.65M+37.46%
2024$6.29M+140.08%
2023$2.62M-77.83%
2022$11.82M-69.36%
2021$38.55M-76.15%
2020$161.66M

FAQs About Aptevo Therapeutics (APVO) Market Cap

As of Aug 1, 2025, the market capitalization of Aptevo Therapeutics (APVO) is $8.65M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Aptevo Therapeutics’s market capitalization has decreased by -12.13%, changing from $9.84M to $8.65M as of Aug 1, 2025.

In the last 3 months, Aptevo Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Aptevo Therapeutics’s market capitalization increased from $2.62M in January to $6.29M in December, reflecting a 140.08% change.

In the past five years, Aptevo Therapeutics (APVO) has had a compound annual growth rate (CAGR) of -47.77% in market capitalization. This means its market cap has shrunk at an average rate of -47.77% per year.

Aptevo Therapeutics (APVO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.